H-1B filings

Does Cytokinetics, Inc. sponsor H-1B?

Yes, according to public filings. Cytokinetics, Inc. filed 23 H-1B labor condition applications in fiscal years 2024-2026, including 5 in fiscal year 2026.

USCIS approved 18 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026555
2025999
2024999

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20264000
20254040
20242040

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Scientist I3$128,939 - $140,000$130,437
Senior Scientist I2$130,437 - $154,000$154,000
Senior Manager, Regulatory Affairs Cmc2$181,542 - $181,542$181,542
IT Business Solutions Lead2$147,368 - $147,368$147,368
Sr. Regulatory Affairs Associate I1$126,000 - $126,000$126,000
Medical Director, Clinical Research Cardiovascular1$310,000 - $310,000$310,000
Senior Manager, Quality Validation1$187,387 - $187,387$187,387
Senior Research Associate1$112,950 - $112,950$112,950
Research Associate II, Medicinal Chemistry1$80,870 - $80,870$80,870
Senior Clinical Pharmacologist1$135,000 - $135,000$135,000

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

Sources

Data release 2026q3, built on October 23, 2026.